Page last updated: 2024-09-03

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Endolymphatic Stromal Myosis

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Endolymphatic Stromal Myosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davidson, R; Feig, B; Hu, W; Khokhar, AR; Kumagai, S; Lee, SJ; Maclean, DS; Mansfield, P; Siddik, ZH; Verschraegen, CF1

Trials

1 trial(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Endolymphatic Stromal Myosis

ArticleYear
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
    Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Ascites; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; Endometrial Stromal Tumors; Female; Humans; Injections, Intraperitoneal; Liposomes; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Radionuclide Imaging; Technetium; Tissue Distribution

2003